Thomas Watkins - 28 Apr 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Apr 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 19:32:40 UTC
Previous filing
03 Jun 2022
Next filing
28 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +3,913 +16% 29,124 28 Apr 2023 Direct F1, F2
holding HZNP Ordinary Shares 55,953 28 Apr 2023 By Trust F2
holding HZNP Ordinary Shares 10,000 28 Apr 2023 By Family Limited Partnership

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Options Exercise $0 -3,913 -100% $0.000000* 0 28 Apr 2023 Ordinary Shares 3,913 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2 19,211 Ordinary Shares previously reported as indirectly held by Trust held directly.